Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Feb 25, 2026)
Date Submitted: Oct 7, 2025
Open Peer Review Period: Oct 8, 2025 - Dec 3, 2025
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Health beliefs and Responses of parents towards Human papillomavirus vaccination in the Middle East: a qualitative systematic review
ABSTRACT
Background:
Human papillomavirus (HPV) is the most frequent sexually transmitted disease in women and the major cause of cervical cancer (CC). Several countries have significantly reduced CC deaths and rates by offering cervical screening and HPV vaccination programs. The number of CC screening and HPV vaccine programs in around 100 countries around the world has led to dramatic reductions in incidence and death rates for the disease. HPV vaccination could prevent up to 70% of HPV-related cervical cancer and 90% of genital warts. HPV vaccination plays an influential role in decreasing CC worldwide. Thus, it is essential to formulate a suitable vaccination program for each nation so that they can combat the life-threatening conditions caused by HPV infection.
Objective:
This study aimed to systematically synthesize the attitudes and health beliefs of Middle Eastern (ME) parents regarding HPV vaccination, and to examine parents' uptake of HPV vaccination in ME nations, as well as assess their children's HPV vaccine uptake.
Methods:
Methods:
This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Since the first HPV vaccination was approved in 2006, PubMed/MEDLINE, Web of Science, CINAHL, and Google Scholar were searched for papers between January 1, 2006, and May 2025.
Results:
Out of the 33 included studies, 32 were quantitative observational (cross-sectional), while one was a qualitative study. The findings were synthesised according to the six components of the health belief model: perceived susceptibility and severity regarding HPV and vaccination, perceived barriers to HPV vaccination uptake, perceived benefits of HPV vaccination, self-efficacy as a measure of HPV vaccination, concerns surrounding HPV vaccination, modifying variables influencing HPV uptake, and parental attitudes towards HPV vaccination uptake. Parents expressed apprehension about their limited knowledge of the virus and vaccine, citing obstacles such as a shortage of healthcare providers, safety concerns, cost, and vaccine availability.
Conclusions:
The knowledge of HPV and its possible carcinogenic consequences in Middle Eastern nations was insufficient. Strategies to improve HPV vaccination uptake included mass medical campaigns, healthcare professional involvement, educational interventions, health insurance coverage, and recommendations from the Ministry of Health. Self-efficacy played a crucial role in enhancing vaccine uptake.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.